Novartis division Sandoz recalls one lot of blood pressure drug

Nov 09, 2018 , Reuters
Novartis said on Thursday its Sandoz division was recalling one lot of losartan tablets after finding traces of a probable carcinogen in the blood pressure drug.

Read the full story...

Trending healthcare news keywords at this moment

risk cancer study care holiday weight holidays higher digital fda opioid diabetes system data drug food healthcare doctors launches hospital beef kids tied women heart blood recalled tip disease court mental research medicaid surgery amp patients finds report obamacare ruling